2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)17-20
Number of pages4
JournalFuture Oncology
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Phenylurea Compounds
Neoadjuvant Therapy
Niacinamide
Protein Kinase Inhibitors
Head and Neck Neoplasms
Antineoplastic Agents
Vascular Endothelial Growth Factor A
Squamous Cell Carcinoma
Biomarkers
sorafenib
Carcinoma, squamous cell of head and neck

Keywords

  • EGFR
  • PDGF-β
  • VEGF
  • biomarker
  • neoadjuvant therapy
  • sorafenib
  • squamous cell carcinoma of the head and neck

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Sorafenib in squamous cell carcinoma of the head and neck : Molecular basis and potential role. / Bhatt, Vijaya R; Ganti, Apar Kishor P.

In: Future Oncology, Vol. 10, No. 1, 01.01.2014, p. 17-20.

Research output: Contribution to journalComment/debate

@article{66ef81fdc07d4c13809006d317c1799a,
title = "Sorafenib in squamous cell carcinoma of the head and neck: Molecular basis and potential role",
keywords = "EGFR, PDGF-β, VEGF, biomarker, neoadjuvant therapy, sorafenib, squamous cell carcinoma of the head and neck",
author = "Bhatt, {Vijaya R} and Ganti, {Apar Kishor P}",
year = "2014",
month = "1",
day = "1",
doi = "10.2217/fon.13.212",
language = "English (US)",
volume = "10",
pages = "17--20",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Sorafenib in squamous cell carcinoma of the head and neck

T2 - Molecular basis and potential role

AU - Bhatt, Vijaya R

AU - Ganti, Apar Kishor P

PY - 2014/1/1

Y1 - 2014/1/1

KW - EGFR

KW - PDGF-β

KW - VEGF

KW - biomarker

KW - neoadjuvant therapy

KW - sorafenib

KW - squamous cell carcinoma of the head and neck

UR - http://www.scopus.com/inward/record.url?scp=84929876207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929876207&partnerID=8YFLogxK

U2 - 10.2217/fon.13.212

DO - 10.2217/fon.13.212

M3 - Comment/debate

C2 - 24328406

AN - SCOPUS:84929876207

VL - 10

SP - 17

EP - 20

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 1

ER -